Peptide Modifications 101: Why Termini Get Capped

Peptides don't just have a beginning and an end for convenience of description. The N-terminus (the free amine group) and C-terminus (the free carboxylic acid group) are the two most chemically reactive spots on the entire molecule. Left unmodified, both ends are exposed to attack by enzymes and prone to unwanted side reactions, which is exactly why so many research peptides are synthesized with capped, rather than free, termini.

N-terminal acetylation is one of the most common caps. An acetyl group is attached to the free amine at the N-terminus, neutralizing its positive charge and blocking it from being recognized and clipped off by aminopeptidases, a class of enzymes that specifically chew through peptides starting from that end. The acetyl cap essentially removes the handle those enzymes need to grab onto.

C-terminal amidation does the analogous job at the other end. Instead of a free carboxylic acid group, the C-terminus is converted into an amide group. This removes the negative charge the free acid would otherwise carry, which changes the peptide's overall polarity and, again, makes it a much poorer substrate for carboxypeptidase enzymes that degrade peptides from the C-terminal side.

Both modifications are typically built in during solid-phase peptide synthesis rather than added afterward. The resin type chosen at the start of synthesis determines whether the finished peptide comes off as a free acid or an amide at the C-terminus, and N-terminal acetylation is usually performed as the final coupling step on the synthesizer, capping the last amino acid added to the chain before cleavage from the resin.

These details matter beyond just chemistry trivia. A peptide's exact terminal chemistry, free acid vs. amide, acetylated vs. free amine, is a defining part of its identity, not a cosmetic detail. It's precisely why a legitimate certificate of analysis specifies the exact sequence and modification state of a peptide, not just its amino acid composition.